No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ICUI240517C85000
- 13.80
- 0.000.00%
15min DelayTrading Dec 7 14:29 ET
0.00High0.00Low
0.00Open13.80Pre Close0 Volume27 Open Interest85.00Strike Price0.00Turnover0.00%IV0.31%PremiumMay 17, 2024Expiry Date22.17Intrinsic Value100Multiplier7DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type--Delta--Gamma4.76Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- 1D
News
ICU Medical, Inc. (NASDAQ:ICUI) First-Quarter Results: Here's What Analysts Are Forecasting For This Year
Spectrum Brands Posts Upbeat Results, Joins AerSale, Sinclair, ICU Medical And Other Big Stocks Moving Higher On Thursday
U.S. stocks were mixed, with the Dow Jones gaining around 100 points on Thursday.Shares of Spectrum Brands Holdings, Inc. (NYSE:SPB) rose sharply during Thursday's session following upbeat earnings.Sp
Shareholders May Be Wary Of Increasing ICU Medical, Inc.'s (NASDAQ:ICUI) CEO Compensation Package
Key Insights ICU Medical to hold its Annual General Meeting on 15th of May Salary of US$775.0k is part of CEO Vivek Jain's total remuneration The total compensation is similar to the average for t
ICU Medical First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Earnings Call Summary | ICU Medical(ICUI.US) Q1 2024 Earnings Conference
The following is a summary of the ICU Medical, Inc. (ICUI) Q1 2024 Earnings Call Transcript:Financial Performance:ICU Medical reported a Q1 revenue of $553 million, indicating a total company growth o
ICU Medical, Inc. (NASDAQ:ICUI) Q1 2024 Earnings Call Transcript
Comments
The recent insider sale of ICU Medical shares at around the current price of US$104 raises caution. The absence of insider buying over the past year and the recent sale does not inspire confidence in the company despite high insider ownership.
Chief Operating Officer Christian Voigtlander Sold A Bunch Of Shares In ICU Medical 1
Analysts hold steady on ICU Medical's revenue estimates and price target despite larger than expected losses. However, they anticipate a significant slowdown in the company's revenue growth, underperforming the wider industry.
The company's lower P/S ratio could be indicative of investor anticipation of less-impressive revenue performance moving forward. Some shareholders appear uneasy due to the company's weaker future prospect in terms of revenue growth.
1
Gainers:
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
In reaction to earnings/guidance:
• $GoodRx(GDRX.US$ +38.5%, $EDGIO(EGIO.US$ +13.5%, $Lemonade(LMND.US$ +10.7%, $Desktop Metal(DM.US$ +8.5%, $ShockWave Medical(SWAV.US$ +8.2%, $Pubmatic(PUBM.US$ +8.1%, $Olaplex(OLPX.US$ +7%, $Vivid Seats(SEAT.US$ +6.4%, $Noble(NE.US$ +6.3%, $Aspen Technology(AZPN.US$ +5.4%, $AAON Inc(AAON.US$ +5%, $Hudbay Minerals(HBM.US$ +5%, $Vivint Smart Home(VVNT.US$ +4.9%, $Vivint Smart Home(VVNT.US$ +4...
21
Read more